<DOC>
	<DOC>NCT01740687</DOC>
	<brief_summary>The purpose of the post approval study is to evaluate the effectiveness and safety of the Essure System when a NovaSure Endometrial Ablation procedure is performed following a successful Essure Confirmation Test.</brief_summary>
	<brief_title>A Study to Evaluate the Effectiveness of Essure Post-NovaSure Radiofrequency Endometrial Ablation Procedure Following a Successful Essure Confirmation Test</brief_title>
	<detailed_description>This study has previously been posted by Conceptus, Inc. After acquiring Conceptus, Inc., Bayer is now the sponsor of the trial.</detailed_description>
	<mesh_term>Menorrhagia</mesh_term>
	<criteria>All inclusion criteria from the Essure Permanent Birth Control System Instructions for Use and/or the NovaSure Impedance Controlled Endometrial Ablation (EA) System Instructions for Use and Controller Operator's Manual will apply. Women experiencing menorrhagia due to benign causes Women who are relying on the Essure microinserts for permanent contraception following a successful Essure Confirmation Test (as applicable to the Post Approval Study) Women willing to accept the risk of pregnancy while relying on the Essure microinserts for prevention of pregnancy following a NovaSure ablation procedure for menorrhagia All exclusion criteria from the Essure Permanent Birth Control System Instructions for Use and/or the NovaSure Impedance Controlled Endometrial Ablation System Instructions for Use and Controller Operator's Manual will apply. Women who previously underwent a fallopian tube sterilization procedure (other than Essure placement) Women who present with any other medical complaints, conditions or symptoms unrelated to the Essure System and/or subsequent NovaSure EA including, but not limited to: Gynecological comorbidities (e.g., pelvic infection, cervicitis, undiagnosed vaginal bleeding, endometrial cancer, myomas, and polyps) Reproductive tract anatomical variants and/or pathology which could make the subject unsuitable for the Essure and/or NovaSure transcervical procedures Women currently wearing an intrauterine device and unwilling to have it removed before NovaSure</criteria>
	<gender>Female</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Endometrial Ablation</keyword>
	<keyword>Permanent Sterilization</keyword>
	<keyword>Essure</keyword>
	<keyword>NovaSure</keyword>
	<keyword>Prevention of Pregnancy</keyword>
</DOC>